Allspring Global Investments Holdings, LLC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 185 filers reported holding TG THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.21 and the average weighting 0.1%.

Quarter-by-quarter ownership
Allspring Global Investments Holdings, LLC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$132,480
-99.5%
15,847
-98.4%
0.00%
-100.0%
Q2 2023$24,259,143
+1922.6%
976,615
+1124.6%
0.04%
+1850.0%
Q1 2023$1,199,409
+1469.2%
79,748
+1134.3%
0.00%
Q4 2022$76,433
+96.0%
6,461
-2.2%
0.00%
Q3 2022$39,000
+875.0%
6,603
+517.1%
0.00%
Q2 2022$4,000
-98.1%
1,070
-95.2%
0.00%
Q1 2022$213,000
-52.9%
22,411
-5.8%
0.00%
-100.0%
Q4 2021$452,00023,7920.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
RA Capital Management 2,813,779$33,568,0003.32%
Opaleye Management Inc. 300,000$3,579,0001.50%
BRIDGER MANAGEMENT, LLC 3,068,315$36,605,0001.21%
SECTORAL ASSET MANAGEMENT INC 1,521,667$18,153,0000.77%
STONERIDGE INVESTMENT PARTNERS LLC 332,576$3,968,0000.53%
Eventide Asset Management 537,600$6,414,0000.32%
Baker Brothers Advisors 2,003,991$23,908,0000.20%
Quantitative Systematic Strategies LLC 25,270$302,0000.08%
Candriam S.C.A. 236,200$2,818,0000.08%
COLUMBUS CIRCLE INVESTORS 705,389$8,415,0000.07%
View complete list of TG THERAPEUTICS INC shareholders